RecruitingNot applicableNCT04735198
Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
Studying Neuroendocrine tumor of the small intestine
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospital Universitari de Bellvitge
- Principal Investigator
- Ricardo Frago MontanuyHospital Universitari de Bellvitge
- Intervention
- Primary tumor surgery(procedure)
- Enrollment
- 100 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (6)
- Hospital Universitari Trias i Pujol, Badalona, Barcelona, Spain
- IDIBELL, Hospital Universitari de Bellvitge., Barcelona, Barcelona, Spain
- Hospital del Mar, Barcelona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron, Barcelona, Barcelona, Spain
- Instituto Catalán de Oncología, L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital Universitario Gregorio Marañón, Madrid, Madrid, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04735198 on ClinicalTrials.govOther trials for Neuroendocrine tumor of the small intestine
Additional recruiting or active studies for the same condition.
See all trials for Neuroendocrine tumor of the small intestine →